11 March 2021
Keynote speakers 2021
Brian Rye, Senior Health-Care Policy Analyst at Bloomberg Intelligence
Brian Rye is the Senior Health-Care Policy Analyst for Bloomberg Intelligence, a dynamic platform for in-depth and independent research available on the Bloomberg professional service at BI <GO>. At BI, Mr. Rye analyzes the impact of U.S. legislation and regulation on the pharmaceutical and health-care sectors.
He brings with him 12 years of experience as an equity research analyst at SunTrust, Raymond James and Janney Montgomery Scott, where he followed biotech, pharmaceutical and other health-care companies. Mr. Rye also served as a senior business management analyst for Booz Allen Hamilton’s civil health group. He received a bachelor’s degree in economics from Vanderbilt University and holds the Chartered Financial Analyst designation.
Sam Fazeli, Director of EMEA Research, Senior Pharmaceutical Analyst of Bloomberg Intelligence
Sam Fazeli is a senior analyst and the EMEA head of Bloomberg Intelligence, a dynamic platform for in-depth research available on the Bloomberg Professional service at BI <GO>. Mr. Fazeli specializes in European pharmaceuticals and biotechnology.
Mr. Fazeli brings with him over 15 years of experience conducting equity research as a pharmaceutical analyst, working at firms such as Nomura International and HSBC.
Prior to joining Bloomberg in 2010, Mr. Fazeli worked at Piper Jaffray, Ltd. as a pharmaceutical analyst and head of European research. Before transitioning to investment banking, Mr. Fazeli was a research scientist for seven years.
Mr. Fazeli has been ranked a top analyst by both the U.K. and Pan-European Extel surveys. He received a bachelor’s of science from Cardiff University, and a Ph.D. in pharmacology from the University of London.